Mimedx Group, Inc.
MDXGNasdaqCIK 1376339HealthcareFiscal year ends Dec 31
Reports and events: 379 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1613:01 ET | 8-K | 8.01 Other events | 0001213900-26-110041 |
| 2026-08-1120:44 ET | 8-K/A | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000082 |
| 2026-07-2920:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000074 |
| 2026-07-2920:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001376339-26-000071 |
| 2026-07-2920:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000070 |
| 2026-06-1620:12 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001376339-26-000052 |
| 2026-04-2920:02 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001376339-26-000033 |
| 2026-04-2920:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000032 |
| 2026-04-2920:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001376339-26-000031 |
| 2026-04-1612:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000021 |
| 2026-02-2521:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000012 |
| 2026-02-2521:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001376339-26-000011 |
| 2026-01-1213:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000003 |
| 2025-10-2920:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000104 |
| 2025-10-2920:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001376339-25-000103 |
| 2025-09-0312:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001376339-25-000093 |
| 2025-07-3020:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000087 |
| 2025-07-3020:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001376339-25-000085 |
| 2025-06-2020:05 ET | 8-K | 5.07 Shareholder vote results | 0001376339-25-000059 |
| 2025-05-1320:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000053 |
| 2025-04-3020:06 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001376339-25-000048 |
| 2025-04-3020:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001376339-25-000045 |
| 2025-04-3020:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000044 |
| 2025-02-2713:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000013 |
| 2025-02-2621:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000011 |
| 2025-02-2621:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001376339-25-000009 |
| 2025-01-1413:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005766 |
| 2024-12-1621:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-279618 |
| 2024-11-1813:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-260490 |
| 2024-10-3020:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-247640 |
| 2024-10-3020:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001376339-24-000065 |
| 2024-07-3120:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-189932 |
| 2024-07-3120:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001376339-24-000063 |
| 2024-06-0720:00 ET | 8-K | 5.07 Shareholder vote results | 0001376339-24-000055 |
| 2024-04-3020:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-125073 |
| 2024-04-3020:04 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001376339-24-000033 |
| 2024-04-2321:58 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001140361-24-021104 |
| 2024-03-2712:24 ET | 8-K | 7.01 Regulation FD disclosure | 0001376339-24-000026 |
| 2024-03-0413:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001376339-24-000011 |
| 2024-02-2821:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-050739 |
| 2024-02-2821:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001376339-24-000009 |
| 2024-01-2213:09 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-011707 |
| 2023-12-2821:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-305186 |
| 2023-12-2721:42 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-304022 |
| 2023-11-1313:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-275400 |
| 2023-10-3020:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001376339-23-000069 |
| 2023-10-3020:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-266161 |
| 2023-09-0521:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001376339-23-000066 |
| 2023-09-0512:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-228137 |
| 2023-08-0120:04 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001376339-23-000063 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.